Brainbees Solutions (Firstcry) IPO vs Emcure Pharma IPO

Comparision between Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO.

IPO Details

Brainbees Solutions (Firstcry) IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd Bofa Securities India Limited Jm Financial Limited Avendus Capital Pvt Ltd	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Brainbees Solutions (Firstcry) IPO is up to ₹4,193.73 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Brainbees Solutions (Firstcry) IPO is ₹465.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹440.00 per share	₹960.00 per share
Issue Price (Upper)	₹465.00 per share	₹1,008.00 per share
Issue Price (Final)	₹465.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)	₹44.00 per share	₹90.00 per share
Market Lot Size	32 shares	14 shares
Fresh Issue Size	3,58,27,957 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹1,666.00 Cr	up to ₹800.00 Cr
OFS Issue Size	5,43,59,733 shares	1,14,28,839 shares
OFS Issue Size (Amount)	up to ₹2,527.73 Cr	up to ₹1,152.03 Cr
Issue Size Total	9,01,87,690 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹4,193.73 Cr	up to ₹1,952.03 Cr

IPO Timetable

Brainbees Solutions (Firstcry) IPO opens on Aug 06, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO is Aug 08, 2024, and Jul 05, 2024, respectively.

	Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
Anchor Bid Date	Aug 05, 2024	Jul 02, 2024
Issue Open	Aug 06, 2024	Jul 03, 2024
Issue Close	Aug 08, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Aug 09, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Aug 12, 2024	Jul 09, 2024
Credit of Share (Tentative)	Aug 12, 2024	Jul 09, 2024
Listing date (Tentative)	Aug 13, 2024	Jul 10, 2024
Anchor Lockin End date 1	Sep 08, 2024	Aug 07, 2024
Anchor Lockin End date 2	Nov 07, 2024	Oct 06, 2024

Financials

Brainbees Solutions (Firstcry) IPO P/E ratio is -69.91, as compared to Emcure Pharma IPO P/E ratio of 34.55.

Brainbees Solutions (Firstcry) IPO

Emcure Pharma IPO

Financial

Brainbees Solutions Limited Financial Information (Restated Consolidated)

Brainbees Solutions Limited's revenue increased by 14.72% and profit after tax (PAT) rose by 33.85% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,510.38	7,119.83	6,197.16
Revenue	6,575.08	5,731.28	2,516.92
Profit After Tax	-321.51	-486.06	-78.69
Net Worth	3,170.74	3,456.26	3,527.94
Reserves and Surplus	3,081.74	3,367.21	3,439.17
Total Borrowing	462.72	176.47	90.16
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

98.90%

Promoter Shareholding (Post-Issue)

78.24%

P/E Ratio

-69.91

34.55

Market Cap

₹24141.75 Cr.

₹19029.89 Cr.

ROE

16.90%%

ROCE

19.37%%

Debt/Equity

0.67

EPS

₹-6.65

₹29.17

RoNW

-8.65%%

16.87%%

Shares Offered

In the Brainbees Solutions (Firstcry) IPO retail investors (RII) are offered 90,12,317 shares while in Emcure Pharma IPO retail investors are offered 90,12,317 shares. Qualified institutional buyers (QIB) are offered 2,70,36,953 shares in Brainbees Solutions (Firstcry) IPO and 38,53,234 shares in Emcure Pharma IPO.

	Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
Anchor Investor Reserveration	4,05,55,428 shares	57,79,850 shares
Market Maker Reserveration
QIB	2,70,36,953 shares	38,53,234 shares
NII	1,35,18,476 shares	28,89,926 shares
RII	90,12,317 shares	67,43,160 shares
Employee	71,258 shares	1,08,900 shares
Others
Total	4,96,39,004 shares	1,37,03,538 shares

Bids Received (Subscription)

Brainbees Solutions (Firstcry) IPO subscribed 12.22x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
QIB (times)	19.30x	191.24x
NII (times)	4.68x	49.32x
Big NII (times)	5.32x	54.90x
Small NII (times)	3.39x	38.16x
RII (times)	2.31x	7.36x
Employee (times)	6.57x	8.81x
Other (times)
Total (times)	12.22x	67.87x

Compare with others

Brainbees Solutions (Firstcry) IPO	Emcure Pharma IPO
Interarch Building Products IPO	Brainbees Solutions (Firstcry) IPO
Orient Technologies IPO	Ceigall India IPO
Unicommerce eSolutions IPO	Akums Drugs and Pharmaceuticals IPO
Ceigall India IPO	Sanstar IPO
Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Sanstar IPO	OLA Electric IPO
Bansal Wire IPO	Vraj Iron and Steel IPO
Emcure Pharma IPO	Aasaan Loans IPO
	Stanley Lifestyles IPO
	DEE Piping Systems IPO

Comments

Add a public comment...